Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Research demystifies fatal glandular disease
Elderly dog
Cushing's disease is commonly found in older dogs

Researchers identify genetic mutations responsible for Cushing's disease

Researchers from the Toyko Institute of Technology have identified genetic mutations responsible for Cushing's disease, a potentially fatal glandular condition.

Cushing's disease arises from benign tumours of the pituitary gland, which excessively secrete the hormone adrenocorticotropin (ACTH). Symptoms include weight gain, muscular weakness, mood and reproductive problems. If left untreated, patients can die from the resulting infections and cardiovascular problems.

Previous studies sought to identify mutations that might cause the disease through sequencing candidate genes and microarray studies, but these made little progress.

In this study, published in Nature Genetics, the research team applied a particular type of DNA sequencing, known as 'exome sequencing' to the pituitary corticotrophin adenoma.

The scientists exome-sequenced samples from 10 patients with Cushing's disease and noticed a small number of protein altering mutations in the adenoma tissue. They further identified the gene harbouring the mutations as uniquitin-specific protease 8 (USP8), and were able to pinpoint the region of USP8 prone to mutation in Cushing's disease.

Previous studies of Cushing's diseases have highlighted strong expression of another gene, epidermal growth factor receptor (EGFR). By examining EGFR in cells expressing the USP8, the researchers behind this latest research demonstrated that this was the result of USP8 mutations inhibiting downregulation of EGFR.

The researchers say that their results “not only identify the first of so far enigmatic driver mutations in corticotroph adenomas but also elucidate a novel mechanism by which the EGFR pathway is constitutively activated in human tumours.”

The researchers say that further research will be required for a more detailes understanding of genetic onset of the disease. 

Become a member or log in to add this story to your CPD history

Building Great Workplaces webinars return

News Story 1
 BVA has announced a new series of its Building Great Workplaces lunchtime webinars.

Launching from 16 July, the sessions will explore patient safety, motivation, client communication and more.

Its first webinar, exploring neurodiversity in the workplace, will take place at 1pm on Thursday, 16 July. It will feature guest speakers from The Vet Project, a group which supports neurodiversity in veterinary environments.

The following three webinars take place in September, October and November.

Booking is open on the BVA website 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.